These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24575098)

  • 1. The Interplay between Daptomycin and the Immune System.
    Kelesidis T
    Front Immunol; 2014; 5():52. PubMed ID: 24575098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action mechanism of daptomycin.
    Taylor SD; Palmer M
    Bioorg Med Chem; 2016 Dec; 24(24):6253-6268. PubMed ID: 27288182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptide daptomycin: Interactions with bacterial and phospholipid membranes, stability of membrane aggregates and micellation in solution.
    Liu B; Karttunen M
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1949-1954. PubMed ID: 29627322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin.
    Kotsogianni I; Wood TM; Alexander FM; Cochrane SA; Martin NI
    ACS Infect Dis; 2021 Sep; 7(9):2612-2619. PubMed ID: 34406007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of multimeric daptomycin bound to lipid nanodiscs formed by calcium-tolerant styrene-maleic acid copolymer.
    Beriashvili D; Spencer NR; Dieckmann T; Overduin M; Palmer M
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183234. PubMed ID: 32145282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin and daptomycin modulate the innate immune response in a murine model of LPS-induced sepsis.
    Muenster S; Zschernack V; Dierig B; Frede S; Baumgarten G; Coburn M; Putensen C; Weisheit CK
    Int J Immunopathol Pharmacol; 2021; 35():20587384211031373. PubMed ID: 34296627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.
    Tran TT; Panesso D; Mishra NN; Mileykovskaya E; Guan Z; Munita JM; Reyes J; Diaz L; Weinstock GM; Murray BE; Shamoo Y; Dowhan W; Bayer AS; Arias CA
    mBio; 2013 Jul; 4(4):. PubMed ID: 23882013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles.
    Scott WR; Baek SB; Jung D; Hancock RE; Straus SK
    Biochim Biophys Acta; 2007 Dec; 1768(12):3116-26. PubMed ID: 17945184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation mechanisms underlying the biosynthesis of daptomycin and related lipopeptides.
    Liao G; Shi T; Xie J
    J Cell Biochem; 2012 Mar; 113(3):735-41. PubMed ID: 22020738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products to drugs: daptomycin and related lipopeptide antibiotics.
    Baltz RH; Miao V; Wrigley SK
    Nat Prod Rep; 2005 Dec; 22(6):717-41. PubMed ID: 16311632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Ligands for Therapeutic Lipopeptides: Daptomycin, Surfactin and Polymyxin.
    Jujjavarapu SE; Dhagat S; Kurrey V
    Curr Drug Targets; 2018; 19(13):1589-1598. PubMed ID: 29189148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145.
    Taylor R; Butt K; Scott B; Zhang T; Muraih JK; Mintzer E; Taylor S; Palmer M
    Biochim Biophys Acta; 2016 Sep; 1858(9):1999-2005. PubMed ID: 27237728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin prevents membrane translocation and permeabilization by daptomycin.
    Zhang T; Muraih JK; Tishbi N; Herskowitz J; Victor RL; Silverman J; Uwumarenogie S; Taylor SD; Palmer M; Mintzer E
    J Biol Chem; 2014 Apr; 289(17):11584-11591. PubMed ID: 24616102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation.
    Beriashvili D; Taylor R; Kralt B; Abu Mazen N; Taylor SD; Palmer M
    Chem Phys Lipids; 2018 Nov; 216():73-79. PubMed ID: 30278162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual inhibition through hybrid oligomer formation of daptomycin and the semisynthetic lipopeptide antibiotic CB-182,462.
    Zhang T; Muraih JK; Mintzer E; Tishbi N; Desert C; Silverman J; Taylor S; Palmer M
    Biochim Biophys Acta; 2013 Feb; 1828(2):302-8. PubMed ID: 23084999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of daptomycin with lipid bilayers: a lipid extracting effect.
    Chen YF; Sun TL; Sun Y; Huang HW
    Biochemistry; 2014 Aug; 53(33):5384-92. PubMed ID: 25093761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin Pore Formation Is Restricted by Lipid Acyl Chain Composition.
    Taylor R; Beriashvili D; Taylor S; Palmer M
    ACS Infect Dis; 2017 Nov; 3(11):797-801. PubMed ID: 29048870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.
    Ledger EVK; Sabnis A; Edwards AM
    Microbiology (Reading); 2022 Feb; 168(2):. PubMed ID: 35118938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin.
    Baltz RH
    Curr Top Med Chem; 2008; 8(8):618-38. PubMed ID: 18473888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.